New York State Common Retirement Fund lowered its position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) by 3.6% during the fourth quarter, Holdings Channel.com reports. The fund owned ...

周三，尽管Tarsus Pharmaceuticals（NASDAQ:TARS）在发布第四季度财报后股价下跌9.3%，H.C. Wainwright仍重申了该公司的买入评级和73.00美元的目标价。根据InvestingPro数据显示，TARS在过去一周下跌16.67%，基于公允价值分析，目前股价显示被低估。H.C.

Tarsus Pharmaceuticals Inc (NASDAQ:TARS) is set to release its Q4 2024 earnings on Feb 25, 2025. The consensus estimate for ...

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) – Equities researchers at Lifesci Capital issued their FY2025 earnings estimates for Tarsus Pharmaceuticals in a report released on ...

Tarsus Pharmaceuticals Inc (TARS) reports robust sales and strategic advancements, despite high operating expenses and market ...

Q4 2024 Earnings Call Transcript February 25, 2025 Tarsus Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...

Barclays lowered the firm’s price target on Tarsus Pharmaceuticals (TARS) to $60 from $62 and keeps an Overweight rating on the shares ...

In trading on Tuesday, shares of Tarsus Pharmaceuticals Inc (Symbol: TARS) entered into oversold territory, hitting an RSI reading of 26.7, after changing hands as low as $41.075 per share.

BofA lowered the firm’s price target on Tarsus Pharmaceuticals (TARS) to $70 from $75 and keeps a Buy rating on the shares. Q4 capped off a ...

TARS Project Management, a leading firm specialising in project management and digital transformation, has increased its stake in UMB Bank to 33 per cent, reinforcing its commitment to expanding ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...